Korea's Green Cross to Build Cell Therapy Facility in China

Green Cross of South Korea will build a new cell therapy manufacturing facility in the Guian New Area of Guizhou province, located in China's southwest corner. In South Korea, the company already produces cell therapy projects including T cell, NK cell, dendritic cell and stem cells. The new China facility will offer cellular therapeutic products for clinical studies and commercial supply, in response, the company says, to the increasing global interest in cellular therapeutic drugs as treatments for serious diseases. More details.... Stock Symbol: (KRX: 5280) Share this with colleagues: // //